|
Arterial Remodeling Technologies |
|
|
3 rue de Verdun-Bat G
Noisy le Roi, 78590 France
phone:+33 161 06 19 92
fax:+33 130 56 50 35
|
|
| Symbol |
Private |
| Founded |
2006 |
| Employees |
4 |
|
|
| www.art-stent.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Bioresorbable Peripheral and Coronary Polymer Stents for Natural Arterial Remodeling Post-Angioplasty |
|
| Management |
| Machiel van der Leest -CEO; Eric Viaud- Chairman |
| |
|
|
| |
|
| Keywords |
| bioresorbable stents, polymer stents, arterial remodeling, metal stent, stent technology |
|
|
|
| Description |
|
Arterial Remodeling Technologies ("ART") is developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. |
|
| Products / Services |
The Company's proprietary, polymer-based technology promotes the natural remodeling of an injured and/or diseased artery after angioplasty or other similar procedures. ART has established proof-of-concept with preclinical implantation studies in iliac and coronary models that can be applied and adapted to a wide variety of stent designs.
|
|
| Technology / Differentiation |
| ART's bioresorbable stents are designed to dismantle in vivo over an optimized time horizon, thus allowing the body's own natural arterial remodeling process to occur, unrestricted by the presence of a permanent metallic stent. |
|
| Market / Customers |
Assuming an adoption rate similar to coated stents, by just the second year of commercialization the worldwide market opportunity for coronary bioresorbable stents could be approximately $3 billion.
|
|
| Strategy |
ART is developing one of the world's first bioresorbable stents made from a biocompatible lactic acid polymer enabling the ART stent to support an artery triggering only minimal local tissue response causing restenosis.
|
|
| Funding |
| ART has raised 10 million ($14.2 million) from VCs Matignon Technologies and SGAM Alternative Investments. |
|
| Status |
| Pre-revenue |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members